SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615774-17-002003
Filing Date
2017-05-02
Accepted
2017-05-02 09:10:19
Documents
3
Period of Report
2017-06-16
Effectiveness Date
2017-05-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A s106006_def14a.htm DEF 14A 679833
2 GRAPHIC proxy1_def14a.jpg GRAPHIC 267259
3 GRAPHIC proxy2_def14a.jpg GRAPHIC 252066
  Complete submission text file 0001615774-17-002003.txt   1396536
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 17803148
SIC: 2834 Pharmaceutical Preparations